| 股票 | 标签 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 京东健康 06618 | 成长兑现 | 药品分销 | 16.5 | 1.67 | 0.0% | 0% | 25% | 9% | 1% | 26% | 8.1% | +32% | +35% | -2% | -33% | -41% | 52% | 1182 |
| 阿里健康 00241 | 成长兑现 | 药品分销 | 23.1 | 2.51 | 7.2% | 166% | 24% | 12% | 0% | 23% | 2.8% | +19% | +43% | -4% | -35% | -39% | 41% | 508 |
| 国药控股 01099 | 中性 | 药品分销 | 6.0 | 0.50 | 5.0% | 30% | 7% | 9% | 3% | 66% | 108.5% | +3% | +9% | -4% | -16% | -12% | 73% | 490 |
| 上海医药 02607 | 中性 | 药品分销 | 7.8 | 0.47 | 4.6% | 36% | 11% | 8% | 7% | 62% | 25.4% | +8% | +24% | +2% | +5% | -2% | 94% | 429 |
| 健康160 02656 | 亏损或困境 | 药品分销 | -58.0 | 12.59 | 0.0% | — | 26% | -94% | 1% | 69% | -3.5% | +10% | +28% | -24% | -82% | -16% | 6% | 35 |
| 上海先锋控股 01345 | 现金流红利 | 药品分销 | 19.1 | 2.26 | 5.5% | 105% | 49% | 11% | 12% | 30% | 5.7% | -12% | -24% | -6% | -6% | +14% | 92% | 27 |
| 药师帮 09885 | 现金流红利 | 药品分销 | 11.9 | 0.93 | 3.4% | 40% | 11% | 6% | 1% | 68% | 16.8% | +22% | +912% | +12% | -30% | -60% | 29% | 25 |
| 思派健康 00314 | 亏损或困境 | 药品分销 | -111.8 | 1.06 | 0.0% | — | 15% | -12% | 0% | 44% | 6.7% | -53% | +63% | +32% | -37% | -71% | 29% | 11 |
| 方舟健客 06086 | 纯久期 | 药品分销 | 116.4 | 3.31 | 0.0% | 0% | 16% | 8% | 6% | 81% | 3.7% | +36% | +101% | -16% | -64% | -79% | 16% | 11 |
| 叮当健康 09886 | 亏损或困境 | 药品分销 | -14.9 | 0.60 | 0.0% | — | 35% | -3% | 2% | 41% | -5.1% | +9% | +86% | -3% | -21% | +9% | 62% | 11 |
| 创美药业 02289 | 现金流红利 | 药品分销 | 11.0 | 0.85 | 6.2% | 68% | 8% | 8% | 7% | 84% | 55.3% | +3% | -9% | +0% | -21% | +0% | 75% | 6 |
| 金活医药集团 01110 | 中性 | 药品分销 | 20.0 | 0.38 | 0.0% | 0% | 27% | 2% | 23% | 52% | 33.5% | -10% | -45% | +5% | -19% | -28% | 54% | 3 |
| 满贯集团 03390 | 中性 | 药品分销 | 7.3 | 0.41 | 0.0% | 0% | 25% | 3% | 5% | 53% | 27.9% | +25% | +157% | -3% | -13% | -22% | 64% | 2 |
| TE HEALTHCARE 06877 | 中性 | 药品分销 | -49.5 | 0.83 | 0.0% | — | 41% | -3% | 0% | 2% | -7.5% | +4% | -163% | -6% | -33% | -55% | 35% | 2 |
| 大健康国际 02211 | 重资产陷阱 | 药品分销 | -2.8 | 0.20 | 0.0% | — | 16% | -8% | 32% | 29% | -68.2% | -33% | -4613% | +28% | -59% | -49% | 13% | 1 |
| 新锐医药 06108 | 亏损或困境 | 药品分销 | -2.9 | 0.11 | 0.0% | — | 12% | -4% | 2% | 3% | -78.1% | +39% | +35% | +16% | -14% | -43% | 51% | 0 |
| 百信国际 00574 | 亏损或困境 | 药品分销 | -2.0 | -0.22 | 0.0% | — | 14% | 0% | 16% | 187% | -31.3% | +5% | -8% | -44% | -42% | -52% | 33% | 0 |
点表头排序。市值单位亿港元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。